The Medical Counselling Committee (MCC), under the Directorate General of Health Services (DGHS), has issued a clarification ...

While hearing a case seeking a Round 5 or Special Stray Vacancy Round for NEET PG 2025 counselling after the National Medical ...

Ahead of NEET UG 2026 -- which opens the door to 1.2 lakh MBBS seats in the country annually -- education expert Nagarajan ...

The Central Bureau of Investigation (CBI) is probing bank loan frauds cumulatively worth Rs 73,000 crore in seven cases ...

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...

Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years, according to an announcement from the company’s CEO on LinkedIn. “The past few ...

This company is the global leader in its specialty area and has successfully expanded into other areas, too. This player aims to generate $13 billion in sales this year. Biotech companies are all ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...

Recursion Pharmaceuticals crashed 90% but JPMorgan upgraded with $11 target implying near tripling. Eli Lilly partnered with Nvidia on a $1B AI drug discovery collaboration using Vera Rubin chips.

The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...

However, the victim’s family expressed distrust in the CBI, citing alleged delay and suspected tampering with evidence, and demanded a court-monitored investigation ...